• THE SCIENTIST
• 19 Aug, 2019

To create an individualized cancer vaccine, researchers must identify cancer-specific peptides called neoantigens, then use a cell-, protein-, or nucleic acid–based platform to deliver those neoantigens to patients to prime the immune system to attack the tumor.Antigen-presenting cells such as dendritic cells (purple) internalize the cancer-specific peptides (bright green)
Read more...